The Next Generation Sequencing Market Forecast 2017-2027

LONDON, October 18, 2017 /PRNewswire/ --

Revenue Prospects by Application (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture and Animal Research, Infectious Diseases, Others) Technology (Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq), Products, End User (Healthcare Institution, Academics, Biotechnology, Pharmaceutical) and Geography

Next Generation Sequencing - our new study reveals trends, R&D progress, and predicted revenues

     (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

Where is the Next Generation Sequencing market heading? If you are involved in this sector you must read this newly updated report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 248-page report provides 192 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Next Generation Sequencing market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 4 segmentations of the Next Generation Sequencing market, with forecasts for 7 Applications, 8 Technologies, 3 Product Types and 5 End Users, each forecasted at a global and regional level.

Global Next Generation Sequencing Market by Application
• Drug Discovery
• Genetic Screening
• Diagnostics
• Personalized Medicine
• Agriculture and Animal Research
• Infectious Diseases
• Others

Global Next Generation Sequencing Market by Technology
• Whole-Genome Sewuencing
• Targeted Re-Sequencing
• Exome Sequencing
• RNA Seq
• Chip Seq
• De Novo Sequencing
• Methyl Seq
• Others 

Global Next Generation Sequencing Market by Product
• Instruments
• Reagents & Consumables
• Services 

Global Next Generation Sequencing Market by End User
• Hospital & Healthcare Institution
• Academics
• Biotechnology
• Pharmaceutical
• Others 

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 7 regional and 17 leading national markets:
• North America:
• US
• Canada

• Latin America:
• Brazil
• Mexico
• Rest of Latin America

• Western Europe:
• Germany
• The UK
• Italy
• France
• Spain
• Nordic
• Benelux
• Rest of Western Europe

• Eastern Europe:
• Russia
• Poland
• Rest of Eastern Europe

• Asia-Pacific:
• Japan
• China
• India
• Australia & New Zealand
• ASEAN
• Rest of Asia-Pacific

• MEA:
• GCC Countries
• South Africa
• Northern Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Next Generation Sequencing market, with a focus on this segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, Russia, Germany and China in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Next Generation Sequencing will surpass $5.6bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Next Generation Sequencing Market report helps you 

In summary, our 248-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for 3 segmentations of the Next Generation Sequencing market, with forecasts for 7 Applications, 8 Technologies, 3 Products and 5 End Users Marine Derived Drug Types, 3 Sources and 5 Applications, each forecasted at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 6 regional and 21 key national markets - See forecasts for the Next Generation Sequencing market in North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, the UK, Italy, France, Nordic Countries, Benelux, China, India, Japan, Australia & New Zealand, ASEAN countries, GCC Countries, South Africa and Northern Africa.
• Stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Next Generation Sequencing market.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain's study is for everybody needing commercial analyses for the Next Generation Sequencing market and leading companies. You will find data, trends and predictions.

Get our report today The Next Generation Sequencing Market Forecast 2017-2027: Revenue Prospects by Application (Drug Discovery, Genetic Screening, Diagnostics, Personalized Medicine, Agriculture And Animal Research, Infectious Diseases, Others) Technology (Whole-Genome Sequencing, Targeted Re-Sequencing, Exome Sequencing, RNA Seq, Chip Seq, De Novo Sequencing, Methyl Seq, Others), Products (Instruments, Reagents & Consumables, Services), End User (Hospital & Healthcare Institution, Academics, Biotechnology, Pharmaceutical, Others) and Geography.

To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

Or click on https://www.visiongain.com/Report/2024/The-Next-Generation-Sequencing-Market-Forecast-2017-2027

Companies Mentioned in the Report 

10x Genomics, Inc.

23andMe, Inc.

Abbott Laboratories

ACT Genomics Co., Ltd.

Adaptive Biotechnologies Corporation

Admera Health

Advanced Biological Laboratories (ABL), S.A.

Agilent Technologies Inc.

AltheaDx, Inc.

Ambry Genetics Corp.

Aperiomics, Inc.

Asuragen, Inc.

Athena Diagnostics, Inc. (A Quest Diagnostics Business)

Base4 Innovation Ltd

Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)

Becton, Dickinson and Company (BD)

BGI

Bina Technologies, Inc. (Part of Roche Sequencing)

BioDiscovery, Inc.

Biomatters Ltd.

bioMérieux S.A.

bioTheranostics, Inc.

Cancer Genetics, Inc.

CareDx, Inc.

Caris Life Sciences

CLC bio (A QIAGEN Company)

Color Genomics, Inc.

Complete Genomics (A BGI Company)

Courtagen Life Sciences, Inc.

Cynvenio Biosystems, Inc.

DNA Electronics Ltd.

Eurofins Genomics

Exosome Diagnostics, Inc.

Foundation Medicine, Inc.

GATC Biotech AG

GenapSys, Inc.

GenDx

GENEWIZ Inc.

Genia Technologies, Inc. (Part of Roche Sequencing)

Genomic Health, Inc.

Genoptix (A Novartis Company)

GnuBIO, Inc. (A Bio-Rad Company)

GRAIL

Guardant Health, Inc.

Helix

HTG Molecular Diagnostics

Human Longevity, Inc.

Illumina, Inc.

Inivata Ltd.

Invitae Corporation

Invivoscribe Technologies, Inc.

Laboratory Corporation of America (LabCorp)

Lasergen, Inc.

MolecularMD Corporation

Myriad Genetics, Inc.

NANTOMICS (Member of the NantWorks ecosystem of companies) Culver city, CA

Natera, Inc.

NeoGenomics, Inc./NeoGenomics Laboratories

N-of-One, Inc.

OncoDNA S.A.

Oncospire Genomics

Oxford Nanopore Technologies Ltd.

Pacific Biosciences of California, Inc.

Pathway Genomics Corporation

Personal Genome Diagnostics, Inc.

Personalis, Inc.

QIAGEN N.V.

Quest Diagnostics

RainDance Technologies, Inc.

Roche

Siemens Healthcare Diagnostics

Stratos Genomics Inc.

Sysmex Corporation

Thermo Fisher Scientific, Inc..

To see a report overview please email Sara Peerun on sara.peerun@visiongain.com